GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe - OSL:GENT - NO0010748866 - Common Stock
53.6 NOK
-1.4 (-2.55%)
GENT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. GENT has an excellent financial health rating, but there are some minor concerns on its profitability. GENT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
GENT had positive earnings in the past year.
GENT had a positive operating cash flow in the past year.
GENT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
With an excellent Return On Assets value of 18.25%, GENT belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 21.37%, GENT belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
GENT has a Return On Invested Capital of 7.59%. This is in the better half of the industry: GENT outperforms 65.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROIC | 7.59% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GENT has a Profit Margin of 25.83%. This is amongst the best in the industry. GENT outperforms 95.00% of its industry peers.
Looking at the Operating Margin, with a value of 12.10%, GENT is in line with its industry, outperforming 60.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 54.19%, GENT is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GENT is destroying value.
The number of shares outstanding for GENT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GENT has about the same amount of shares outstanding.
The debt/assets ratio for GENT has been reduced compared to a year ago.
2.2 Solvency
GENT has an Altman-Z score of 16.04. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.04, GENT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
GENT has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
GENT has a Debt to FCF ratio of 0.33. This is amongst the best in the industry. GENT outperforms 91.67% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that GENT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, GENT belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 16.04 |
ROIC/WACC0.89
WACC8.51%
2.3 Liquidity
GENT has a Current Ratio of 5.47. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of GENT (5.47) is better than 98.33% of its industry peers.
GENT has a Quick Ratio of 3.78. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.78, GENT belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 2103.43% over the past year.
The Revenue has grown by 11.68% in the past year. This is quite good.
GENT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.96% yearly.
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
3.2 Future
The Earnings Per Share is expected to grow by 62.29% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 31.72% on average over the next years. This is a very strong growth
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.93, GENT is valued on the expensive side.
Based on the Price/Earnings ratio, GENT is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
GENT is valuated rather cheaply when we compare the Price/Earnings ratio to 26.28, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.76 indicates a rather expensive valuation of GENT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 61.67% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of GENT to the average of the S&P500 Index (33.61), we can say GENT is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.93 | ||
| Fwd PE | 19.76 |
4.2 Price Multiples
GENT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GENT is more expensive than 61.67% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as GENT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 87.32 | ||
| EV/EBITDA | 26.77 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GENT's earnings are expected to grow with 62.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GENT has a yearly dividend return of 0.73%, which is pretty low.
Compared to an average industry Dividend Yield of 2.37, GENT has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, GENT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.73% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (11/11/2025, 4:19:49 PM)
53.6
-1.4 (-2.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap826.51M
Revenue(TTM)163.38M
Net Income(TTM)42.19M
Analysts85.71
Price Target68.34 (27.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.73% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.93 | ||
| Fwd PE | 19.76 | ||
| P/S | 5.06 | ||
| P/FCF | 87.32 | ||
| P/OCF | 41.55 | ||
| P/B | 4.19 | ||
| P/tB | 4.98 | ||
| EV/EBITDA | 26.77 |
EPS(TTM)2.69
EY5.02%
EPS(NY)2.71
Fwd EY5.06%
FCF(TTM)0.61
FCFY1.15%
OCF(TTM)1.29
OCFY2.41%
SpS10.6
BVpS12.81
TBVpS10.76
PEG (NY)0.34
PEG (5Y)N/A
Graham Number27.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROCE | 9.86% | ||
| ROIC | 7.59% | ||
| ROICexc | 12.65% | ||
| ROICexgc | 17.14% | ||
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% | ||
| FCFM | 5.79% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 115.57% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.08% | ||
| Profit Quality | 22.43% | ||
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 16.04 |
F-Score5
WACC8.51%
ROIC/WACC0.89
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y257.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8223.43%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
What is the valuation status of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for GENT stock?
The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 19.93 and the Price/Book (PB) ratio is 4.19.